These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 18715332

  • 1. Applying the benefits of the AwM study in the clinic.
    Dodick DW.
    Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
    [Abstract] [Full Text] [Related]

  • 2. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ.
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [Abstract] [Full Text] [Related]

  • 3. Early treatment in migraine: how strong is the current evidence?
    Gendolla A.
    Cephalalgia; 2008 Sep; 28 Suppl 2():28-35. PubMed ID: 18715330
    [Abstract] [Full Text] [Related]

  • 4. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 5. Clinical benefits of early triptan therapy for migraine.
    Láinez M.
    Cephalalgia; 2004 Apr; 24 Suppl 2():24-30. PubMed ID: 15595991
    [Abstract] [Full Text] [Related]

  • 6. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
    Goadsby PJ, Zanchin G, Geraud G, de Klippel N, Diaz-Insa S, Gobel H, Cunha L, Ivanoff N, Falques M, Fortea J.
    Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
    [Abstract] [Full Text] [Related]

  • 7. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 8. Review of clinical trials using early acute intervention with oral triptans for migraine management.
    Dowson AJ, Mathew NT, Pascual J.
    Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
    [Abstract] [Full Text] [Related]

  • 9. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK, Maizels M, Reeves DL, Levinson DM, Evans JK.
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [Abstract] [Full Text] [Related]

  • 10. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J, García-Moncó C, Roig C, Yusta Izquierdo A, López-Gil A, eMAX Study Group.
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [Abstract] [Full Text] [Related]

  • 11. What do patients want from acute migraine treatment?
    Gallagher R.
    Cephalalgia; 2004 Oct; 24 Suppl 2():8-15. PubMed ID: 15595989
    [Abstract] [Full Text] [Related]

  • 12. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R, Martin V, Adelman J, Diamond M, Sajjan S, Hu XH.
    Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
    [Abstract] [Full Text] [Related]

  • 13. Almotriptan for the treatment of acute migraine: a review of early intervention trials.
    Antonaci F, De Cillis I, Cuzzoni MG, Allena M.
    Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858
    [Abstract] [Full Text] [Related]

  • 14. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, AEGIS Investigator Study Group.
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [Abstract] [Full Text] [Related]

  • 15. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 16. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.
    Klapper J, Lucas C, Røsjø Ø, Charlesworth B, ZODIAC study group.
    Cephalalgia; 2004 Nov; 24(11):918-24. PubMed ID: 15482352
    [Abstract] [Full Text] [Related]

  • 17. Acute management of migraine.
    Chowdhury D.
    J Assoc Physicians India; 2010 Apr; 58 Suppl():21-5. PubMed ID: 21049703
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [Abstract] [Full Text] [Related]

  • 19. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
    Lipton RB, Cutrer FM, Goadsby PJ, Ferrari MD, Dodick DW, McCrory D, Liberman JN, Williams P.
    Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
    [Abstract] [Full Text] [Related]

  • 20. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC.
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.